Clearpoint Neuro Inc (CLPT)

Feb 27, 2025, 11:18 PM EST - 4 weeks ago

ClearPoint Neuro: Drug Delivery Prospects Continue To Strengthen

Feb 26, 2025, 7:17 PM EST - 5 weeks ago

ClearPoint Neuro, Inc. (CLPT) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 4:05 PM EST - 5 weeks ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results

Feb 14, 2025, 8:00 AM EST - 6 weeks ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025

Feb 12, 2025, 4:15 PM EST - 7 weeks ago

ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula

Jan 27, 2025, 4:05 PM EST - 2 months ago

ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0

Nov 13, 2024, 6:15 PM EST - 5 months ago

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain

Nov 10, 2024, 9:35 AM EST - 5 months ago

ClearPoint Neuro: Near-Term Volatility Is No Concern

Nov 7, 2024, 10:31 PM EST - 5 months ago

ClearPoint Neuro, Inc. (CLPT) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 5 months ago

ClearPoint Neuro Reports Third Quarter 2024 Results

Oct 31, 2024, 4:05 PM EDT - 5 months ago

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024

Oct 17, 2024, 4:05 PM EDT - 5 months ago

ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024

Aug 26, 2024, 4:05 PM EDT - 7 months ago

ClearPoint Neuro Announces Early Repayment of $10 Million Note

Aug 14, 2024, 9:33 AM EDT - 8 months ago

ClearPoint: Growth Tailwinds Are Only Just Beginning To Emerge (Rating Downgrade)

Aug 8, 2024, 7:39 PM EDT - 8 months ago

ClearPoint Neuro: My Favorite Growth Stock

Aug 8, 2024, 7:25 AM EDT - 8 months ago

ClearPoint Neuro, Inc. (CLPT) Q2 2024 Earnings Call Transcript

Jul 17, 2024, 4:05 PM EDT - 9 months ago

ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024

Jun 21, 2024, 5:11 AM EDT - 10 months ago

ClearPoint Neuro: Solid Progress Still Not Reflected In The Share Price

Jun 20, 2024, 8:45 AM EDT - 10 months ago

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial

Jun 20, 2024, 8:30 AM EDT - 10 months ago

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons

Jun 1, 2024, 9:00 AM EDT - 10 months ago

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System

May 7, 2024, 10:40 PM EDT - 11 months ago

ClearPoint Neuro, Inc. (CLPT) Q1 2024 Earnings Call Transcript

Apr 25, 2024, 2:30 AM EDT - 1 year ago

ClearPoint Neuro: Macro-Induced Multiple Compression

Apr 16, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations

Mar 19, 2024, 8:07 AM EDT - 1 year ago

ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency

Mar 12, 2024, 11:39 PM EDT - 1 year ago

ClearPoint Neuro, Inc. (CLPT) Q4 2023 Earnings Call Transcript

Mar 12, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results

Mar 1, 2024, 4:05 PM EST - 1 year ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024

Feb 29, 2024, 8:00 AM EST - 1 year ago

ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock

Feb 28, 2024, 4:45 PM EST - 1 year ago

ClearPoint Neuro Launches Proposed Public Offering of Common Stock

Feb 15, 2024, 8:19 AM EST - 1 year ago

ClearPoint Neuro: Potential Inflection Point

Jan 24, 2024, 4:05 PM EST - 1 year ago

ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo

Jan 22, 2024, 4:05 PM EST - 1 year ago

ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe

Jan 8, 2024, 4:05 PM EST - 1 year ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue

Nov 14, 2023, 8:00 AM EST - 1 year ago

NeuroOne: A Hidden Contender Against ClearPoint In The Brain Drug Delivery Arena

NMTC

Nov 9, 2023, 7:38 PM EST - 1 year ago

ClearPoint Neuro, Inc. (CLPT) Q3 2023 Earnings Call Transcript

Oct 26, 2023, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023

Aug 21, 2023, 5:45 AM EDT - 1 year ago

ClearPoint Neuro Continues To Make Progress

Jul 25, 2023, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Announce Second Quarter 2023 Results August 8, 2023

Jun 9, 2023, 8:40 AM EDT - 1 year ago

Top 5 Health Care Stocks That Are Set To Fly In Q2

BLTE COO IRTC STAA

Jun 5, 2023, 5:02 AM EDT - 1 year ago

ClearPoint Neuro: I Continue To Rate The Stock A 'Buy'

May 24, 2023, 9:25 AM EDT - 2 years ago

ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

May 18, 2023, 4:01 PM EDT - 2 years ago

ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference

May 11, 2023, 8:05 PM EDT - 2 years ago

ClearPoint Neuro, Inc. (CLPT) Q1 2023 Earnings Call Transcript

May 10, 2023, 4:05 PM EDT - 2 years ago

ClearPoint Neuro to Present Investigational Research and Showcase Novel Innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles

Apr 28, 2023, 4:42 PM EDT - 2 years ago

ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023

Apr 18, 2023, 4:05 PM EDT - 2 years ago

ClearPoint Neuro Announces Agreement with NE Scientific to Integrate Gene Therapy Infusion Coverage Tool into ClearPoint Maestro® Brain Model

Apr 13, 2023, 4:05 PM EDT - 2 years ago

ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil

Apr 11, 2023, 4:05 PM EDT - 2 years ago

ClearPoint Neuro Extends Software License and Research Agreement with Philips to Include Fully Automatic Subnuclei Segmentation for DBS